Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions

The COCCOS Study: Implementing and Evaluating a Transition Program for Young Persons With Chronic Conditions

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

A study is undertaken to examine the feasibility of the newly developed transition program in adolescents with type 1 diabetes, asthma and obesity in a multicentric setting. Specific objectives for this study are: (1) examining the impact of the program in terms of patient-reported health outcomes, (2) examining patients' and healthcare providers' experiences related to the program implementation process, and (3) examining the impact of the program in terms of cost-effectiveness.

Who May Be Eligible (Plain English)

Who May Qualify: For participants in the intervention group (IG): - 17 years old; - diagnosed with type 1 diabetes, asthma and/or obesity; - who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; - are Dutch speaking; - planned to transfer to adult care within the next 12 months. For participants in the control group (CG): - age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months) - diagnosed with type 1 diabetes, asthma and/or obesity; - who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; - are Dutch speaking; - planned to transfer to adult care within the next 12 months. Who Should NOT Join This Trial: Applicable for both CG and IG: \- patients with severe mental, cognitive or neurological problems will be excluded Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion criteria: For participants in the intervention group (IG): * 17 years old; * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. For participants in the control group (CG): * age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months) * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. Exclusion criteria: Applicable for both CG and IG: \- patients with severe mental, cognitive or neurological problems will be excluded

Treatments Being Tested

OTHER

Transition program

Transition Consultation: Pediatric HCP introduces the transition process to AYA and family. A contact person is assigned (ideally the AYA's trusted HCP), along with someone from the AYA's personal network. Key points are recorded in the Individualized Transition Plan (ITP). Independent Visit: AYA has a solo consultation (parents briefly step out). They complete the Ready Steady Go checklist. The ITP is updated, and concerns are discussed. Joint Consultation: Pediatric and adult HCPs meet with the AYA. A new adult contact is assigned, and the AYA picks a pediatric contact for feedback. Checklist is completed again. Feedback Moment: After transfer, the pediatric contact checks in. The checklist guides discussion; feedback is shared across teams, and follow-up arranged if needed.

Locations (1)

Ghent University Hospital
Ghent, Belgium